Olympian Clinical Research

JUNE 8, 2022

Consider the PRECLUDE study – a clinical research study for patients with episodic migraines. We are researching an investigational study drug to understand if it could potentially help in the preventive treatment of episodic migraine in adults. What is a Clinical Research Study? About Migraines.

Clinical Research 52

Clinical Research Research Treatment Doctors 52

PPD

JUNE 20, 2024

Acceleration in every step of clinical research is critical to pharmaceutical developers. Yet, today’s clinical research sponsors face significant challenges. Rather than accepting the persistent delays in clinical research as disruptive, yet unavoidable, we believe they underscore the need for greater efficiency.

Clinical Research 52

Clinical Research Research Clinical Trials Pharmaceuticals 52

Drug Target Review

APRIL 7, 2025

Susceptibility or risk biomarkers can detect the likelihood of a patient developing a disease or medical condition, which is crucial for treatments that are most effective before the onset of symptoms. Diagnostic biomarkers typically confirm or establish a diagnosis and are often used in selecting patient populations for clinical trials.

Clinical Development 69

Clinical Development Clinical Trials Clinical Pharmacology Trials 69

Olympian Clinical Research

OCTOBER 30, 2020

At Olympian Clinical Research we’ve gotten a chance to work with countless Schizophrenia patients over the years through our clinical trials, and we know just how untrue many of the common assumptions about Schizophrenia really are. . Myth #2: People with Schizophrenia are violent. Learn More.

Clinical Research 98

Clinical Research Clinical Trials Treatment Disease 98

Conversations in Drug Development Trends

OCTOBER 14, 2024

Fortunately, advances in clinical research are providing hope for better treatments and outcomes. With the support of global networks like ours at Worldwide Clinical Trials (Worldwide), autoimmune and bone health research is accelerating, providing new solutions to patients around the world.

Research 52

Research Clinical Trials Therapies Immune Response 52

Conversations in Drug Development Trends

MAY 1, 2024

For clinical research professionals, this journey often involves reconciling differing feedback from regulatory agencies, each with unique standards, priorities, and expectations. Searching for overlap might allow the investigational product to have a more rapid marketing authorization in multiple regions. Japan, and China.

Clinical Research 69

Clinical Research Trials Clinical Trials Research 69

Advarra

SEPTEMBER 14, 2023

In the clinical research space, GxP is a set of quality regulations and guidelines designed to establish the safety, efficacy, and integrity of pharmaceuticals, medical devices, and clinical trials. This blog explores key concepts, regulations, and the importance of GxP in delivering successful clinical trials.

Clinical Research 52

Clinical Research Research Compliance Clinical Trials 52

Vial

MAY 20, 2024

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? billion in 2022 and is projected to reach US$10.2

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

PPD

OCTOBER 17, 2024

In China, the high incidence of solid tumors is driving an urgent need for advanced therapies, spurring the push for new treatment approaches. There has also been an increase in government and regulatory support for CGT trials, in conjunction with an increase in investments for these products to get to market.

Therapies 97

Therapies Clinical Trials Clinical Research Trials 97

PPD

JUNE 27, 2024

In general, ongoing research in AA is focused on molecules whose mechanism of actions and effectiveness have been proven in psoriasis and atopic dermatitis. CorEvitas will be deploying AA focus groups among physicians and patients to provide insights for pragmatic clinical trial designs. Accelerate your alopecia areata treatments.

Treatment 52

Treatment Clinical Trials Clinical Research Small Molecule 52

PPD

SEPTEMBER 16, 2024

In a recent panel discussion at DIA Global , our experts explored how these elements are reshaping clinical research and drug discovery. It is critical for drug developers to partner with a knowledgeable CRO partner like the PPD clinical research business of Thermo Fisher Scientific.

Clinical Development 98

Clinical Development Clinical Trials Clinical Research Trials 98

Conversations in Drug Development Trends

NOVEMBER 5, 2024

In preparation for World Orphan Drug Congress Europe, we interviewed Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, and Derek Ansel, MS, LCGC, Vice President, Therapeutic Strategy Lead, Rare Disease, to hear their insights into the current progress in rare disease research and their hopes for 2025.

Disease 52

Disease Clinical Trials Therapies Clinical Research 52

Olympian Clinical Research

SEPTEMBER 3, 2020

Finding the right medication can be a frustrating process, though, since there’s no “one-size-treats-all” medication for depression on the market. We just started a clinical trial to explore a new treatment option for patients who suffer from moderate to severe depression. We’re on a mission to help those patients! .

Clinical Trials 98

Clinical Trials Treatment Clinical Research Trials 98

PPD

SEPTEMBER 24, 2024

The enterprise of delivering life-changing medicines to patients involves a complex ecosystem, and in many ways, three key players reside at the core: drug sponsors, the contract research organizations (CROs) that support them and the clinical research sites directly engaging with patients in the trial.

Clinical Research 98

Clinical Research Clinical Trials Trials Research 98

PPD

DECEMBER 16, 2024

The drug development industry faces rising costs and increasingly complex protocols as top challenges, with 49% of developers citing costs as their primary concern and 39% pointing to protocol complexity as a key hurdle, according to a recent survey of 150 drug developers worldwide by the PPD clinical research business of Thermo Fisher Scientific.

Drug Development 52

Drug Development Clinical Trials Compliance Trials 52

The Pharma Data

AUGUST 31, 2021

In addition, as part of the label update, this indication has been revised to be for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who are not eligible for any platinum-containing chemotherapy.

FDA Approval 52

FDA Approval Treatment FDA Research Laboratories 52

Olympian Clinical Research

MARCH 3, 2020

Many of the life-changing medical treatments that are available for patients have all been tested through a research study. There’s no doubt that research volunteers play a significant role in getting these vital solutions out on the market for the people in need. Enrolling Studies.

Clinical Trials 52

Clinical Trials Trials Clinical Research Treatment 52

PPD

SEPTEMBER 25, 2023

The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. In Asia , personalized and precision medicine has become the driving force behind transformative clinical trials.

Drug Development 104

Drug Development Clinical Trials Drugs Trials 104

The Pharma Data

MARCH 26, 2021

Despite continuous innovations in the treatment landscape, unmet needs remain. Overall, the number of treatment-emergent adverse events reported was similar between the ponesimod and teriflunomide treated groups, and the majority were mild/moderate and did not warrant treatment discontinuation. vs. 9.4%), nasopharyngitis (19.3%

Treatment 52

Treatment Pharmaceutical Companies Pharmaceuticals FDA Approval 52

Cytel

JANUARY 23, 2023

Ever since the first immune checkpoint inhibitor was approved for market nearly twelve years ago, the industry has witnessed a steady rise in the search for new immunotherapies. This has aligned with the broader curation of a number of new dose-escalation and efficacy designs for clinical development in oncology.

Clinical Development 52

Clinical Development Trials Clinical Research Treatment 52

Olympian Clinical Research

FEBRUARY 26, 2019

Choosing to participate in a clinical research study is a very personal decision, and people choose to participate in clinical research studies for a variety of reasons. We know that participating in a research study may seem overwhelming and intimidating, but sometimes the potential benefits far exceed any uncertainty.

Research 40

Research Clinical Research Clinical Trials Doctors 40

Advarra

OCTOBER 15, 2024

The International Council for Harmonisation (ICH) good clinical practice (GCP) guidelines are critical in ensuring the safety and rights of clinical trial participants. R3 acknowledges no clinical trial can be flawless, but it encourages organizations to adapt their processes and systems to address the most critical risks effectively.

Clinical Trials 52

Clinical Trials Trials Clinical Research International 52

Conversations in Drug Development Trends

APRIL 3, 2024

By: Sue Batchelor, Executive Director, Oncology Project Management Radiopharmaceuticals represent a cutting-edge frontier in oncology treatment, offering the promise of highly targeted therapy with the potential to revolutionize cancer care. One such approach is standardizing imaging protocols across your trial sites — consistency is key.

Trials 81

Trials Clinical Trials Compliance Treatment 81

Vial

FEBRUARY 29, 2024

From the pre-clinical testing and lead discovery, to human testing and post-marketing surveillance, CROs offer a comprehensive array of services that sponsors now commonly seek out. There’s no doubt the market value for CROs is trending upwards; in 2022 alone, the CRO market was estimated to be worth US$56.7

Clinical Trials 52

Clinical Trials Trials Clinical Research Drug Development 52

Vial

APRIL 18, 2024

The urgency for novel therapeutic approaches makes ophthalmology a rapidly growing domain of clinical research. Market research indicates significant growth in the ophthalmic clinical trials market, driven by increased disease prevalence, demand for ocular treatments, and rising research funding.

Clinical Trials 52

Clinical Trials Trials Treatment Clinical Research 52

H1 Blog

NOVEMBER 29, 2023

Every day, patients around the globe are waiting for life-saving treatments to reach the market. The initial report, which came out In 2013 from PhRMA/EFPIA, recognized the importance of data sharing and supported initiatives to enhance clinical trial data transparency and promote scientific advancements.

Clinical Trials 59

Clinical Trials Trials Drug Development Treatment 59

Precision for Medicine

DECEMBER 1, 2023

December 1, 2023 — Precision for Medicine, the first global biomarker-driven clinical research organization, is the recipient of a new accreditation from The College of American Pathologists (CAP) for its tissue and histopathology laboratory in Winston-Salem, North Carolina. Winston-Salem, Nc.,

Laboratories 45

Laboratories Clinical Trials Clinical Research Compliance 45

Crown Bioscience

MAY 4, 2021

Why are cancer treatments for children lagging behind the latest advancements in clinical oncology? Crown Bioscience Director Mike Batey takes a closer look at pediatric cancer and how recent regulatory changes and additional research focus may deliver new therapies for kids.

Research 52

Research Pharmaceutical Companies Licensing Licensing 52

The Pharma Data

MARCH 30, 2021

In Europe, KEYTRUDA is approved for the treatment of adult patients with advanced or metastatic urothelial carcinoma (bladder cancer) who are not eligible for cisplatin-containing chemotherapy and whose tumors express PD-L1 with a Combined Positive Score (CPS) ? Merck has the industry’s largest immuno-oncology clinical research program.

FDA Approval 52

FDA Approval Treatment FDA Therapies 52

The Pharma Data

NOVEMBER 9, 2020

The trial looked at a combination of Keytruda from Merck and Lenvima from Eisai for the treatment of advanced renal cell carcinoma (RCC). Merck and Eisai intend to discuss their new data with global regulatory authorities, with the intent to submit marketing authorization applications based on these results.

Research Laboratories 52

Research Laboratories Laboratories Treatment Therapies 52

Precision for Medicine

JUNE 26, 2023

Baseline Control’s expertise will become part of Project Farma, Precision for Medicine’s existing biomanufacturing strategy and execution group, expanding the scope of its manufacturing solutions for life science companies and driving greater speed and efficiency in bringing new drugs to market. Bethesda, Md.,

Science 40

Science Small Molecule Clinical Research Engineering 40

Conversations in Drug Development Trends

AUGUST 23, 2023

A public health professional by training, Kahn has spent the last 13 years working to reduce the time it takes to bring promising, new treatments to the patients that need them most. Her fellow panelists represented a diverse group of stakeholders across clinical research, including patient advocates, sponsors, sites, and the FDA itself.

FDA 96

FDA Trials Clinical Trials Disease 96

The Pharma Data

DECEMBER 21, 2020

Extension eliminates out-of-pocket costs for treatment, allowing impacted members to focus on health and recovery for as long as the public health emergency lasts. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. OAKLAND, Calif. , OAKLAND, Calif. ,

Virus 52

Virus Clinical Research Treatment Disease 52

PPD

NOVEMBER 9, 2023

Instead of the standard approach where studies are designed to address a primary focus, a parallel study method — a format that incorporates multiple endpoints and objectives, modifications, treatment arms and dose selections into a single protocol — is being rapidly adopted.

Clinical Development 52

Clinical Development Drug Development Clinical Research Treatment 52

Conversations in Drug Development Trends

FEBRUARY 26, 2024

It plays a significant role in patient recruitment and retention, both of which are vital to maintaining timelines, decreasing program costs, and gaining market approval. From a combined perspective, somewhere along the way, we tend to be able to land at what is the true design of clinical research,” says Perez.

Clinical Trials 59

Clinical Trials Trials Disease Clinical Research 59

The Pharma Data

JANUARY 12, 2021

We are all aware that the process between patient identification and enrollment is significantly inefficient and ineffective, especially for those patients that are currently not getting treatment in research-oriented sites.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceutical Companies 52

Precision for Medicine

MAY 24, 2023

CRO Leadership Awards recognize companies judged by customers as exceeding expectations BETHESDA, MD, May 25, 2023 – Precision for Medicine, the first biomarker-driven clinical research organization (CRO), announces its wide recognition in the 2023 CRO Leadership Awards.

Clinical Trials 40

Clinical Trials Clinical Research Science Trials 40